A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Grimm, Martin ^a   Schmitt, Steffen ^b   Teriete, Peter ^c   Biegner, Thorsten ^a   Stenzl, Arnulf ^a   Hennenlotter, Jörg ^a   Muhs, Hans Joachim ^d   Munz, Adelheid ^a   Nadtotschi, Tatjana ^a   König, Klemens ^a   Sänger, Jörg ^e   Feyen, Oliver ^f   Hofmann, Heiko ^f   Reinert, Siegmar ^a   Coy, Johannes F ^f  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c BURNHAM INSTITUTE   (United States)

^d Clemenshospital Muenster ^*  (Germany)

^e Institute of Pathology   (Germany)

^f Darmstadt and Tavargenix GmbH   (Germany)

Author keywords

Apo10; Biomarker; DNaseX; Early detection and diagnosis; EDIM (epitope detection in monocytes); EDIM blood test; TKTL1

Indexed keywords

APO10 PROTEIN; BIOLOGICAL MARKER; TRANSKETOLASE; TRANSKETOLASE LIKE PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAMMAL CELL; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DEOXYRIBONUCLEASE I; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOCYTES; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; MUSCLE PROTEINS; NECK; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; TRANSKETOLASE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84888799072     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-569     Document Type: Article

References (49)

1. Cummings J, Raynaud F, Jones L, Sugar R, Dive C. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer 2010, 103:1313-1317. 10.1038/sj.bjc.6605910, 2990602, 20924371.
2. Silva SD, Agostini M, Nishimoto IN, Coletta RD, Alves FA, Lopes MA, Kowalski LP, Graner E. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol 2004, 40:688-696. 10.1016/j.oraloncology.2004.01.004, 15172638.
3. Los M, Neubuser D, Coy JF, Mozoluk M, Poustka A, Schulze-Osthoff K. Functional characterization of DNase X, a novel endonuclease expressed in muscle cells. Biochemistry 2000, 39:7365-7373. 10.1021/bi000158w, 10858283.
4. Taper HS. Altered deoxyribonuclease activity in cancer cells and its role in non toxic adjuvant cancer therapy with mixed vitamins C and K3. Anticancer Res 2008, 28:2727-2732.
5. Martelli AM, Tabellini G, Bressanin D, Ognibene A, Goto K, Cocco L, Evangelisti C. The emerging multiple roles of nuclear Akt. Biochim Biophys Acta 2012, 1823:2168-2178. 10.1016/j.bbamcr.2012.08.017, 22960641.
6. Locasale JW, Cantley LC. Altered metabolism in cancer. BMC Biol 2010, 8:88. 10.1186/1741-7007-8-88, 2892450, 20598111.
7. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
8. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899. 10.1038/nrc1478, 15516961.
9. Kobayashi CI, Suda T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J Cell Physiol 2012, 227:421-430. 10.1002/jcp.22764, 21448925.
10. Scatena R. Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation. Adv Exp Med Biol 2012, 942:287-308. 10.1007/978-94-007-2869-1_13, 22399428.
11. Coy JF, Dubel S, Kioschis P, Thomas K, Micklem G, Delius H, Poustka A. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 1996, 32:309-316. 10.1006/geno.1996.0124, 8838793.
12. Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005, 51:257-273.
13. Feyen O, Coy JF, Prasad V, Schierl R, Saenger J, Baum RP. EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies. Future Oncol 2012, 8:1349-1359. 10.2217/fon.12.98, 23130932.
14. Hu LH, Yang JH, Zhang DT, Zhang S, Wang L, Cai PC, Zheng JF, Huang JS. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007, 18:427-433. 10.1097/CAD.0b013e328013d99e, 17351395.
15. Xu X, Zur Hausen A, Coy JF, Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer 2009, 124:1330-1337. 10.1002/ijc.24078, 19065656.
16. Langbein S, Zerilli M, Zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP, Steidler A, Weiss C, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006, 94:578-585. 10.1038/sj.bjc.6602962, 2361175, 16465194.
17. Zerilli M, Amato MC, Martorana A, Cabibi D, Coy JF, Cappello F, Pompei G, Russo A, Giordano C, Rodolico V. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. Cancer 2008, 113:936-944. 10.1002/cncr.23683, 18615628.
18. Hartmannsberger D, Mack B, Eggert C, Denzel S, Stepp H, Betz CS, Gires O. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Cancer Lett 2010, 300:20-29.
19. Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, Zhao M, Rudek MA, Ha PK, Califano JA. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res 2010, 16:857-866. 10.1158/1078-0432.CCR-09-2604, 2824550, 20103683.
20. Zhang S, Yang JH, Guo CK, Cai PC. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett 2007, 253:108-114. 10.1016/j.canlet.2007.01.010, 17321041.
21. Schmidt M, Voelker HU, Kapp M, Krockenberger M, Dietl J, Kammerer U. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J Cancer Res Clin Oncol 2010, 136:219-225. 10.1007/s00432-009-0652-y, 19655166.
22. Yuan W, Wu S, Guo J, Chen Z, Ge J, Yang P, Hu B. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo. Cancer Biol Ther 2010, 9:710-716. 10.4161/cbt.9.9.11431, 20200485.
23. Kayser G, Sienel W, Kubitz B, Mattern D, Stickeler E, Passlick B, Werner M, Zur Hausen A. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 2011, 43(7):719-724. 10.1097/PAT.0b013e32834c352b, 22027741.
24. Schwaab J, Horisberger K, Strobel P, Bohn B, Gencer D, Kahler G, Kienle P, Post S, Wenz F, Hofmann WK, et al. Expression of transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011, 11:363. 10.1186/1471-2407-11-363, 3176245, 21854597.
25. Diaz-Moralli S, Tarrado-Castellarnau M, Alenda C, Castells A, Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS One 2011, 6:e25323. 10.1371/journal.pone.0025323, 3181277, 21980427.
26. Volker HU, Hagemann C, Coy J, Wittig R, Sommer S, Stojic J, Haubitz I, Vince GH, Kammerer U, Monoranu CM. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Am J Clin Pathol 2008, 130:50-57. 10.1309/6H9844AMMET82DBJ, 18550470.
27. Lange CA, Tisch-Rottensteiner J, Bohringer D, Martin G, Schwartzkopff J, Auw-Haedrich C. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology 2012, 119:1924-1929. 10.1016/j.ophtha.2012.03.037, 22658715.
28. Bentz S, Cee A, Endlicher E, Wojtal KA, Naami A, Pesch T, Lang S, Schubert P, Fried M, Weber A, et al. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion 2013, 88:182-192. 10.1159/000355015, 24193262.
29. Jansen N, Coy JF. Diagnostic use of epitope detection in monocytes blood test for early detection of colon cancer metastasis. Future Oncol 2013, 9:605-609. 10.2217/fon.13.8, 23560382.
30. Herwig R, Pelzer A, Horninger W, Rehder P, Klocker H, Ramoner R, Pinggera GM, Gozzi C, Konwalinka G, Bartsch G. Measurement of intracellular versus extracellular prostate-specific antigen levels in peripheral macrophages: a new approach to noninvasive diagnosis of prostate cancer. Clin Prostate Cancer 2004, 3:184-188. 10.3816/CGC.2004.n.029, 15636686.
31. Leers MP, Nap M, Herwig R, Delaere K, Nauwelaers F. Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer: a three-color/five-parameter flow cytometric study on peripheral blood samples. Am J Clin Pathol 2008, 129:649-656. 10.1309/THWWRU8L42U5H9PB, 18343793.
32. Parihar A, Eubank TD, Doseff AI. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun 2010, 2:204-215. 10.1159/000296507, 2956013, 20375558.
33. Grimm M, Krimmel M, Polligkeit J, Alexander D, Munz A, Kluba S, Keutel C, Hoffmann J, Reinert S, Hoefert S. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. Eur J Cancer 2012, 48:3186-3197. 10.1016/j.ejca.2012.05.027, 22784549.
34. Sobin LH, Ch W. UICC. TNM Classification of Malignant Tumors 2010, Berlin: Springer Verlag, 7.
35. Hamilton SR, Aaltonen LA. Pathology and Genetics. Tumours of the Digestive System 2000, Lyon: IARC Press, 3.
36. Walker RA. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 2006, 49:406-410. 10.1111/j.1365-2559.2006.02514.x, 16978204.
37. Tuominen VJ, Tolonen TT, Isola J. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry. Histopathology 2012, 60:758-767. 10.1111/j.1365-2559.2011.04142.x, 22296215.
38. Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010, 12:R56. 10.1186/bcr2615, 2949645, 20663194.
39. Edington KG, Loughran OP, Berry IJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog 1995, 13:254-265. 10.1002/mc.2940130408, 7646764.
40. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981, 41:1657-1663.
41. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 75:457-487.
42. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
43. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972, 1987-2001.
44. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
45. Shiokawa D, Tanaka M, Kimura T, Hashizume K, Takasawa R, Ohyama H, Fujita K, Yamada T, Tanuma S. Characterization of two DNase gamma-specific monoclonal antibodies and the in situ detection of DNase gamma in the nuclei of apoptotic rat thymocytes. Biochem Biophys Res Commun 2000, 275:343-349. 10.1006/bbrc.2000.3249, 10964668.
46. Wanka C, Steinbach JP, Rieger J. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem 2012, 287:33436-33446. 10.1074/jbc.M112.384578, 3460445, 22887998.
47. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
48. Warburg O, Posener K, Negolein E. Über den Stoffwechsel der Carcinomzelle. Biochem Z 1924, 309-344.
49. Caligiuri MA. Human natural killer cells. Blood 2008, 112:461-469. 10.1182/blood-2007-09-077438, 2481557, 18650461.